OUR RESEARCH TEAMS
(Overview)

PLATELETS & INFLUENZA: INRA PRESS RELEASE

Stacks Image 3890

Platelets play a role in severe pulmonary infections associated with influenza viruses. This has been revealed for the first time by researchers from Team 1 of LVTS in collaboration with researchers from INRA and the Université Claude Bernard Lyon 1. This work has been published on April 1, 2015 in the American Journal of Respiratory and Critical Care Medicine. Their results show that anti-platelet drugs represent an effective therapeutic support against serious influenza.

3 April 2015

DIDER LETOURNEUR AT THE FRENCH PARLIAMENT

Stacks Image 1058

Over the next five years, a large number of biological drug patents will fall into the public domain. Already, many pharmaceutical companies develop and put on the drug market "Biosimilars" on the same pattern as for the generic chemical drugs. Because substantial savings are expected with this interchangeability, a public audition was held at the French Parliament on 29 January 2015. Didier Letourneur was one the experts that the Committee invited to this session.

29 January 2015

MEET ACTICOR BIOTECH TEAM IN PARIS ON JULY 1st, 2014

Stacks Image 3832

Some recent news on the Acticor Biotech team, a company dedicated to the development of an innovative, safe and effective treatment of ischemic stroke:

• Acticor is currently selecting its main lead to enter the development phase.

• Dr Gilles Avenard is the new President of the company.

Dr DIDIER LETOURNEUR ON FRANCE 5

Stacks Image 3821

Dr Didier Letourneur (Director of LVTS and leader of Team 3) was invited at the "Le Magazine de la Santé" on France 5 (27 May 2014) where he was interviewed on the recent publication from his group on a new strategy to facilitate tissue and organ repair (Press release).

27 May 2014

Dr GIUSEPPINA CALIGIURI SPOTTED IN THE 'INTERNATIONAL INNOVATION' JOURNAL

Stacks Image 3850

The last issue of 'International Innovation', a journal for the global dissemination resource for the wider scientific, technology and research communities, focuses on the Women in Healthcare. Giuseppina (Team 1) has been invited to expose her research and to give her opinion on gender issues in medicine.

20 May 2014

Dr INGRID GOMEZ GRANTED THE 2013 GEMI'S THESIS PRIZE

Stacks Image 3626

Dr Ingrid Gomez (Team 5) was granted the 2013 GREMI thesis prize for her research on the role the PGE2 and of the hydrogen sulfur in the pathophysiology of human varicose veins.

13 May 2014

Dr DIDIER LETOURNEUR ON BFMTV

Stacks Image 3737

Dr Didier Letourneur (Director of LVTS and leader of Team 3) was invited at the "Votre Santé m'intéresse" on BFM TV (3 May 2014) where he was interviewed on the recent publication from his group on a new strategy to facilitate tissue and organ repair (Press release).

3 May 2014

ACTICOR SPOTTED IN BIOTECHFINANCES

Stacks Image 3572

The agreement between ACTICOR, a biotech hosted within the LVTS and created on the basis of the work from Martine Jandrot-Perrus (Team 1), Christian Gachet (U949) and Philippe Billiad (Institut Paris Sud d'Innovation Thérapeutique) is highlighted in the April issue of the BiotechFinances journal.

29 April 2014

Dr DIDIER LETOURNEUR: INNOVATIVE STRATEGY TO FACILITATE ORGAN REPAIR

Stacks Image 3501

A significant breakthrough could revolutionize surgical practice and regenerative medicine. The team led by Ludwik Leibler (Laboratoire Matière Molle et Chimie CNRS/ESPCI Paris Tech) and the team headed by Didier Letourneur from the LVTS (INSERM U1148/Universités Paris Diderot and Paris 13), has just demonstrated that the principle of adhesion by aqueous solutions of nanoparticles can be used in vivo to repair soft-tissue organs and tissues. When applied to skin, it closes deep wounds in a few seconds and provides aesthetic, high quality healing. Finally, this solution has s strong potential for delivering drugs and strengthening tissues. This work has just been published on the website of the journal Angewandte Chemie.

17 April 2014
Read the full Press Release : French / English | Read the paper

FACT: FRENCH ALLIANCE FOR CARDIOVASCULAR TRIALS

Stacks Image 3636

The FACT (French Alliance for Cardiovascular Trials) network, chaired by Prof PG Steg (LVTS Team 5) has been selected as an « Investigative Network Initiative » and will receive a 5-year financial support from the F-CRIN (French part of ECRIN - European Clinical Research Infrastructures Network). FACT is an academic research network that federates more than 20 sites throughout France that are interested in doing clinical trials in the field of coronary artery disease, atherothrombosis, and cardiovascular complications of diabetes.

25 January 2014

PROF. DOMINIQUE LE GULUDEC APPOINTED CHAIRPERSON OF THE BOARD OF DIRECTORS OF IRSN

Stacks Image 1034

PHD in Biophysics, Dominique Le Guludec is Professor of Biophysics and Nuclear Medicine at University Paris 7. She is head of the Department of Nuclear Medicine, Hôpital Bichat, AP-HP, Paris, since 1994. She is also head of a research team of our Inserm Unit 1148, member of the Executive Committee of the EANM, and member of the National Council of Universities (CNU section 4301).

6 December 2013

'FUCO-CHEM' COORDINATED BY CÉDRIC CHAUVIERRE SELECTED AS A LABCOM

Stacks Image 1023

The 'Agence nationale de la recherche' has selected the first 7 common laboratories between research organisms and private companies as part of the « Labcom » program.
The project
FucoChem has been selected for its research on marine polysaccharides to be used as cardiovascular biotherapies. This project is coordinated by Cédric Chauvierre (Team 3 Inserm U1148). It involves the laboratory of polymer bioengineering (Université Paris-Nord and Inserm) and the 'Algues & Mer' company.

IMMATIS PROJECT LEADED BY DIDIER LETOURNEUR SUPPORTED BY OSEO

Stacks Image 572

For the 15th edition of the National competition for the '’aide à la création d’entreprises de technologies innovantes', the minister of 'Enseignement supérieur et de la Recherche' in association with OSEO has granted 55 projects in the “création-développement” and 120 projects in "Emergence".

The project
IMMATIS coordinated by D Letourneur (Team 3) was selected in the “création-développement” category. It was ranked in second position in terms of financial support.

6 July 2013

NANOATHERO - A NEW FP7 LARGE SCALE PROGRAM COORDINATED BY U698

Stacks Image 362

Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility

NanoAthero is a Large Scale European-funded project under the 7th Framework Programme for Research. The main objective of this project is to address more in depth prospects of improved diagnosis and treatment of atherosclerosis by means of nanotechnology.

Coordination :
Didier Letourneur (Team 3; Inserm U1148, CHU X. Bichat)

10 December 2012

RECENT PUBLICATIONS
(Full Listing)